{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:24:27Z","timestamp":1791321867069,"version":"4.3.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We report 28 patients with advanced chronic graft-versus-host disease (cGVHD) treated with extracorporeal photopheresis (ECP). All had failed conventional immunosuppressive therapy. Of the patients, 27 had extensive cGVHD and 20 had more than 50% cutaneous surface area involvement. ECP was initiated approximately 2 years after onset of cGVHD and 3 years following allogeneic stem cell transplantation and administered fortnightly for 4 months and then monthly. Response was assessed using quantifiable disease measures, including skin score, liver function tests (LFTs), blood counts, and lung function tests. Regression analysis allowed assessment of any pretreatment clinical or laboratory parameters that predicted response. There were 25 patients who completed 3 months and 21 who completed 6 months of treatment. Systemic immunosuppression was stable or reduced in 86% of patients. There were 3 patients who died from cGVHD. After 6 months, median skin scores were 53% lower (P = .003) in sclerodermoid and lichenoid disease. Of 6 patients with mucosal ulceration, 3 improved. A nonsignificant improvement of LFTs occurred. We infer that ECP is effective even in patients with extensive cutaneous cGVHD of 2 years duration that is resistant to conventional therapy. Furthermore, both sclerodermoid and lichenoid subtypes responded. However, no baseline parameters predicted a favorable response to ECP, so patient selection must continue to be made on clinical grounds.<\/jats:p>","DOI":"10.1182\/blood-2002-11-3351","type":"journal-article","created":{"date-parts":[[2003,4,28]],"date-time":"2003-04-28T20:14:21Z","timestamp":1051560861000},"page":"1217-1223","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":104,"title":["Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response"],"prefix":"10.1182","volume":"102","author":[{"given":"Edward D.","family":"Seaton","sequence":"first","affiliation":[{"name":"From St John's Institute of Dermatology, St Thomas' Hospital, London, England; and the Departments of Haematology and Dermatology, Hammersmith Hospital Campus, Imperial College, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Szydlo","sequence":"additional","affiliation":[{"name":"From St John's Institute of Dermatology, St Thomas' Hospital, London, England; and the Departments of Haematology and Dermatology, Hammersmith Hospital Campus, Imperial College, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Kanfer","sequence":"additional","affiliation":[{"name":"From St John's Institute of Dermatology, St Thomas' Hospital, London, England; and the Departments of Haematology and Dermatology, Hammersmith Hospital Campus, Imperial College, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane F.","family":"Apperley","sequence":"additional","affiliation":[{"name":"From St John's Institute of Dermatology, St Thomas' Hospital, London, England; and the Departments of Haematology and Dermatology, Hammersmith Hospital Campus, Imperial College, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Russell-Jones","sequence":"additional","affiliation":[{"name":"From St John's Institute of Dermatology, St Thomas' Hospital, London, England; and the Departments of Haematology and Dermatology, Hammersmith Hospital Campus, Imperial College, London, England."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219051021800_REF1","unstructured":"Ratanatharathorn V, Nash RA, Przepiorka D, et al. Phase III study comparing methotrexate and Tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92: 2303-2314."},{"key":"2020021219051021800_REF2","unstructured":"Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96: 2062-2068."},{"key":"2020021219051021800_REF3","doi-asserted-by":"crossref","unstructured":"Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. New Engl J Med. 1999;341: 14-21.","DOI":"10.1056\/NEJM199907013410103"},{"key":"2020021219051021800_REF4","doi-asserted-by":"crossref","unstructured":"Wingard JR, Piantadosi S, Vogelsang GB, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood. 1989;74: 1428-1435.","DOI":"10.1182\/blood.V74.4.1428.1428"},{"key":"2020021219051021800_REF5","doi-asserted-by":"crossref","unstructured":"Flowers MED, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin N Am. 1999;13: 1091-1112.","DOI":"10.1016\/S0889-8588(05)70111-8"},{"key":"2020021219051021800_REF6","doi-asserted-by":"crossref","unstructured":"Gaziev D, Galimberti M, Lucarelli G, Polchi P. Chronic graft-versus-host disease: is there an alternative to the conventional treatment? Bone Marrow Transplant. 2000;25: 689-696.","DOI":"10.1038\/sj.bmt.1702235"},{"key":"2020021219051021800_REF7","unstructured":"Deeg HJ. Modification of allointeractions after blood transfusion and marrow transplantation by ultraviolet light. Semin Hematol. 1992;29: 95-101."},{"key":"2020021219051021800_REF8","doi-asserted-by":"crossref","unstructured":"Ullrich SE. Photoactivation of T-cell function with psoralen and UVA radiation suppressed the induction of experimental murine graft-versus-host disease across major histocompatibility complex barriers. J Invest Dermatol. 1991;96: 303-308.","DOI":"10.1111\/1523-1747.ep12465134"},{"key":"2020021219051021800_REF9","doi-asserted-by":"crossref","unstructured":"Edelson R, Berger C, Basparro F, et al. Successful treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New Engl J Med. 1987;316: 297-303.","DOI":"10.1056\/NEJM198702053160603"},{"key":"2020021219051021800_REF10","doi-asserted-by":"crossref","unstructured":"Evans AV, Wood BP, Scarisbrick JJ, et al. Extracorporeal photopheresis in Sezary syndrome: hematological parameters as predictors of response. Blood. 2001;98: 1298-1301.","DOI":"10.1182\/blood.V98.5.1298"},{"key":"2020021219051021800_REF11","doi-asserted-by":"crossref","unstructured":"Barr ML, Meiser BM, Eisen HJ, et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med. 1998;339: 1744-1751.","DOI":"10.1056\/NEJM199812103392404"},{"key":"2020021219051021800_REF12","doi-asserted-by":"crossref","unstructured":"Constanzo-Nordin MR, Hubbell EA, O'Sullivan EJ, et al. Successful treatment of heart transplant rejection with photopheresis. Transplant. 1992;53: 808-815.","DOI":"10.1097\/00007890-199204000-00021"},{"key":"2020021219051021800_REF13","unstructured":"Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994;14: 845-848."},{"key":"2020021219051021800_REF14","unstructured":"Rossetti F, Dall'Amico R, Crovetti G, et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant. 1996;18(suppl 2) 175-181."},{"key":"2020021219051021800_REF15","doi-asserted-by":"crossref","unstructured":"Dall'Amico R, Rossetti F, Zulian F, et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol. 1997;97: 848-854.","DOI":"10.1046\/j.1365-2141.1997.1092927.x"},{"key":"2020021219051021800_REF16","doi-asserted-by":"crossref","unstructured":"Smith EP, Sniecinski I, Dagis AC, et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biol Blood Marrow Transplant. 1998;4: 27-37.","DOI":"10.1016\/S1083-8791(98)90007-6"},{"key":"2020021219051021800_REF17","doi-asserted-by":"crossref","unstructured":"Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92: 3098-3104.","DOI":"10.1182\/blood.V92.9.3098"},{"key":"2020021219051021800_REF18","doi-asserted-by":"crossref","unstructured":"Dippel E, Goerdt S, Orfanos CE. Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus host disease: observations in four patients. Dermatology. 1999;198: 370-374.","DOI":"10.1159\/000018150"},{"key":"2020021219051021800_REF19","doi-asserted-by":"crossref","unstructured":"Child FJ, Ratnavel R, Watkins P, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1999;23: 881-887.","DOI":"10.1038\/sj.bmt.1701733"},{"key":"2020021219051021800_REF20","doi-asserted-by":"crossref","unstructured":"Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion. 2001;41: 1299-1305.","DOI":"10.1046\/j.1537-2995.2001.41101299.x"},{"key":"2020021219051021800_REF21","doi-asserted-by":"crossref","unstructured":"Besnier DP, Chabannes D, Mahe B, et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation. 1997;64: 49-54.","DOI":"10.1097\/00007890-199707150-00010"},{"key":"2020021219051021800_REF22","doi-asserted-by":"crossref","unstructured":"Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation. 1995;59: 149-151.","DOI":"10.1097\/00007890-199501150-00029"},{"key":"2020021219051021800_REF23","doi-asserted-by":"crossref","unstructured":"Konstantinow A, Balda B-R, Starz H, Gnekow A, Heidemann P. Chronic graft-versus-host disease: successful treatment with extracorporeal photochemotherapy: a follow up [letter]. Br J Dermatol. 1996;135: 1007-1008.","DOI":"10.1046\/j.1365-2133.1996.d01-1113.x"},{"key":"2020021219051021800_REF24","doi-asserted-by":"crossref","unstructured":"Alcindor T, Gorgun G, Miller BK. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood. 2001;98: 1622-1625.","DOI":"10.1182\/blood.V98.5.1622"},{"key":"2020021219051021800_REF25","doi-asserted-by":"crossref","unstructured":"Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long term clinicopathological study of 20 Seattle patients. Am J Med. 1980;69: 204-217.","DOI":"10.1016\/0002-9343(80)90380-0"},{"key":"2020021219051021800_REF26","doi-asserted-by":"crossref","unstructured":"Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus host disease. Blood. 2001;97: 1219-1226.","DOI":"10.1182\/blood.V97.5.1219"},{"key":"2020021219051021800_REF27","unstructured":"Kaheleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadhold CB, LeRoy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol. 1986;4: 367-369."},{"key":"2020021219051021800_REF28","doi-asserted-by":"crossref","unstructured":"McDonald GB, Shukman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation: part II. Gastroenterology. 1986;90: 770-784.","DOI":"10.1016\/0016-5085(86)91137-6"},{"key":"2020021219051021800_REF29","unstructured":"Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;16: 169-173."},{"key":"2020021219051021800_REF30","doi-asserted-by":"crossref","unstructured":"Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342: 1334-1349.","DOI":"10.1056\/NEJM200005043421806"},{"key":"2020021219051021800_REF31","doi-asserted-by":"crossref","unstructured":"Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol. 1999;107: 707-711.","DOI":"10.1046\/j.1365-2141.1999.01773.x"},{"key":"2020021219051021800_REF32","doi-asserted-by":"crossref","unstructured":"Aringer M, Graininger WB, Smolen JS, et al. Photopheresis treatment enhances CD95 (Fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol. 1997;36: 1276-1282.","DOI":"10.1093\/rheumatology\/36.12.1276"},{"key":"2020021219051021800_REF33","doi-asserted-by":"crossref","unstructured":"Fadock VA, Bratton D, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-\u03b2, PGE-2 and PAF. J Clin Invest. 1998;101: 890-898.","DOI":"10.1172\/JCI1112"},{"key":"2020021219051021800_REF34","doi-asserted-by":"crossref","unstructured":"Voll R, Herrman E, Roth E, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells [letter]. Nature. 1997;390: 350-351.","DOI":"10.1038\/37022"},{"key":"2020021219051021800_REF35","doi-asserted-by":"crossref","unstructured":"Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285: 412-415.","DOI":"10.1126\/science.285.5426.412"},{"key":"2020021219051021800_REF36","doi-asserted-by":"crossref","unstructured":"Klingemann HG. Relevance and potential of natural killer cells in stem cell transplantation. Biol Blood Marrow Transplant. 2000;9: 90-99.","DOI":"10.1016\/S1083-8791(00)70071-1"},{"key":"2020021219051021800_REF37","doi-asserted-by":"crossref","unstructured":"Asai O, Longo D, Tian Z, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumour effects by activated natural killer cells after allogenic bone marrow transplantation. J Clin Invest. 1998;101: 1835-1842.","DOI":"10.1172\/JCI1268"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/4\/1217\/1689622\/h81603001217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/4\/1217\/1689622\/h81603001217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T19:53:56Z","timestamp":1581537236000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/4\/1217\/17103\/Influence-of-extracorporeal-photopheresis-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,15]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-11-3351","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,15]]}}}